FDA Approves First Medication for Obstructive Sleep Apnea
The U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first prescription medication for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity, providing a new…